Mallinckrodt Archives -

Mallinckrodt moves closer to resolving its opioid liability hangover

https://pharmaphorum.com/news/mallinckrodt-moves-closer-to-resolving-its-opioid-liability-hangover/

AI device cleared by FDA to spot lesions during colonoscopy

https://pharmaphorum.com/news/ai-device-cleared-by-fda-to-spot-lesions-during-colonoscopy/

Mallinckrodt’s liver disease drug terlipressin edges FDA advisory panel

https://pharmaphorum.com/news/mallinckrodts-liver-disease-drug-terlipressin-edges-fda-advisory-panel/

Mallinckrodt, Novoteris’ nitric oxide will start COVID-19 trial

https://pharmaphorum.com/news/mallinckrodt-novoteris-nitric-oxide-will-start-covid-19-trial/

Mallinckrodt proposes $1.6bn deal to settle opioid litigation

https://pharmaphorum.com/news/mallinckrodt-proposes-1-6bn-deal-to-settle-opioid-litigation/

Purdue preps bankruptcy as opioid settlement bid stumbles; report

https://pharmaphorum.com/news/purdue-preps-bankruptcy-as-opioid-settlement-bid-stumbles-report/

Facing opioid liability risk, Mallinckrodt stalls generics split

https://pharmaphorum.com/news/facing-opioid-liability-risk-mallinckrodt-stalls-generics-split/

Troubled Mallinckrodt pays $1.2bn for Sucampo

https://pharmaphorum.com/news/troubled-mallinckrodt-pays-1-2bn-sucampo/

Mallinckrodt pays US authorities $100m in pricing case

https://pharmaphorum.com/news/mallincrodt-pays-us-authorities-100m-pricing-case/

Search